Why choose us

  • Expertise BioVirtus can execute large long-confinement studies with up to 45 subjects.
  • Effectiveness Thanks to a large database of subjects BioVirtus guarantees swift and effective recruitment, screening and enrolment.
  • Easiness We have the ability to quickly enrol patients with various diseases.     

Study Type & Design

The BioVirtus team has broad experience in conducting even most complex protocols with most demanding design:

  • single and multiple dose
  • fast, fed and steady state
  • open-label
  • single- and double-blind
  • parallel
  • 2, 3, 4-way cross-over
  • ascending dose
  • pilot and pivotal
  • long confinement

BioVirtus Research Site specializes in the following types of clinical studies:

  • first-in-man
  • proof-of-concept
  • bioavailability and drug metabolism
  • bioequivalence
  • therapeutic equivalence
  • pharmacokinetics (PK)
  • pharmacodynamics (PD)
  • genotyping
  • drug interaction
  • dose escalation
  • food effect
  • biosimilars
  • new forms of products
  • safety profile and product tolerance
  • medical experiments
  • special populations
  • healthy subjects.